ProShares Trust II [GLL] Filings |
|
ProShares Trust II [EUO] Filings |
|
ProShares Trust II [YCL] Filings |
|
ProShares Trust II [SCO] Filings |
|
ProShares Trust II [VIXM] Filings |
|
ProShares Trust II [BOIL] Filings |
|
ProShares Trust II [KOLD] Filings |
|
ProShares Trust II [UCO] Filings |
|
ProShares Trust II [SVXY] Filings |
|
ProShares Trust II [UVXY] Filings |
|
ProShares Trust II [VIXY] Filings |
|
ProShares Trust II [ZSL] Filings |
|
ProShares Trust II [ULE] Filings |
|
ProShares Trust II [AGQ] Filings |
|
10-Q | [2023-05-08] |
10-K | [2023-02-28] |
10-Q | [2022-11-08] |
10-Q | [2022-08-09] |
10-Q | [2022-05-09] |
10-K | [2022-02-25] |
S-1 | [2022-02-15] |
S-1 | [2021-12-16] |
S-1 | [2021-11-16] |
10-Q | [2021-11-05] |
S-1 | [2021-09-15] |
10-Q | [2021-08-06] |
10-Q | [2021-05-07] |
10-K | [2021-02-19] |
S-1 | [2021-02-16] |
10-Q | [2020-11-09] |
S-1 | [2020-08-12] |
10-Q | [2020-08-10] |
10-Q | [2020-05-08] |
S-1 | [2020-03-06] |
10-K | [2020-02-28] |
10-Q | [2019-11-08] |
10-Q | [2019-08-09] |
10-Q | [2019-05-10] |
S-1 | [2019-03-08] |
10-K | [2019-03-01] |
S-1 | [2018-11-30] |
10-Q | [2018-11-09] |
10-Q | [2018-08-09] |
10-Q | [2018-05-10] |
10-K | [2018-03-01] |
S-1 | [2018-02-13] |
10-Q | [2017-11-09] |
S-1 | [2017-09-29] |
S-1 | [2017-09-28] |
10-Q | [2017-08-09] |
S-1 | [2017-05-26] |
S-1 | [2017-05-19] |
S-1 | [2017-05-12] |
10-Q | [2017-05-09] |
S-1 | [2017-05-08] |
10-K | [2017-03-01] |
S-1 | [2017-02-07] |
S-1 | [2016-12-05] |
10-Q | [2016-11-09] |
10-Q | [2016-08-09] |
10-Q | [2016-05-09] |
10-K | [2016-02-29] |
10-Q | [2015-11-09] |
10-Q | [2015-08-10] |
10-Q | [2015-05-11] |
S-1 | [2015-03-13] |
10-K | [2015-03-02] |
10-Q | [2014-11-07] |
S-1 | [2014-10-28] |
S-1 | [2014-08-15] |
10-Q | [2014-08-11] |
S-1 | [2014-06-18] |
10-Q | [2014-05-12] |
10-K | [2014-03-03] |
10-Q | [2013-11-12] |
10-Q | [2013-08-09] |
10-Q | [2013-05-10] |
S-1 | [2013-04-29] |
10-K | [2013-03-01] |
S-1 | [2012-12-05] |
10-Q | [2012-11-09] |
S-1 | [2012-08-31] |
10-Q | [2012-08-09] |
10-Q | [2012-05-10] |
10-K | [2012-02-29] |
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Mid-Term Futures ETF |
||||
☒ | Accelerated Filer | ☐ | ||||
Non-Accelerated Filer |
☐ | Smaller Reporting Company | ||||
Emerging Growth Company |
PROSHARES TRUST II
Table of Contents
Page | ||||
Part I. FINANCIAL INFORMATION |
||||
F-1 | ||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
1 | |||
Item 3. Quantitative and Qualitative Disclosures About Market Risk. |
25 | |||
39 | ||||
Part II. OTHER INFORMATION |
||||
40 | ||||
40 | ||||
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. |
42 | |||
44 | ||||
44 | ||||
44 | ||||
45 |
Item 1. |
Financial Statements. |
Index |
||||
Documents |
Page |
|||
Statements of Financial Condition, Schedule of Investments, Statements of Operations, Statements of Changes in Shareholders’ Equity, and Statements of Cash Flows: |
||||
F-2 | ||||
F-7 | ||||
F-12 | ||||
F-17 | ||||
F-22 | ||||
F-27 | ||||
F-32 | ||||
F-37 | ||||
F-42 | ||||
F-47 | ||||
F-52 | ||||
F-57 | ||||
F-62 | ||||
F-67 | ||||
F-72 | ||||
F-77 | ||||
F-85 | ||||
F-86 |
March 31, 2023 (unaudited) |
December 31, 2022 |
|||||||
Assets |
||||||||
Short-term U.S. government and agency obligations (Note 3) (cost $ |
$ | $ | ||||||
Cash |
||||||||
Segregated cash balances with brokers for futures contracts |
||||||||
Receivable on open futures contracts |
||||||||
Interest receivable |
||||||||
Total assets |
||||||||
Liabilities and shareholders’ equity |
||||||||
Liabilities |
||||||||
Payable for capital shares redeemed |
||||||||
Brokerage commissions and futures account fees payable |
||||||||
Payable to Sponsor |
||||||||
Total liabilities |
||||||||
Commitments and Contingencies (Note 2) |
||||||||
Shareholders’ equity |
||||||||
Shareholders’ equity |
||||||||
Total liabilities and shareholders’ equity |
$ | $ | ||||||
Shares outstanding |
||||||||
Net asset value per share |
$ | $ | ||||||
Market value per share (Note 2) |
$ | $ | ||||||
Principal Amount |
Value |
|||||||
Short-term U.S. government and agency obligations |
||||||||
( |
||||||||
U.S. Treasury Bills ^^ : |
||||||||
$ | $ | |||||||
Total short-term U.S. government and agency obligations |
||||||||
(cost $ |
$ | |||||||
Number of Contracts |
Notional Amount at Value |
Unrealized Appreciation (Depreciation)/Value |
||||||||||
VIX Futures – Cboe, expires April 2023 |
$ | $ | ||||||||||
VIX Futures – Cboe, expires May 2023 |
||||||||||||
$ | ||||||||||||
^^ |
Three Months Ended March 31, |
||||||||
2023 |
2022 |
|||||||
Investment Income |
||||||||
Interest |
$ | $ | ||||||
|
|
|
|
|||||
Expenses |
||||||||
Management fee |
||||||||
Brokerage commissions |
||||||||
Futures accounts fees |
||||||||
|
|
|
|
|||||
Total expenses |
||||||||
|
|
|
|
|||||
Net investment income (loss) |
( |
) | ||||||
|
|
|
|
|||||
Realized and unrealized gain (loss) on investment activity |
||||||||
Net realized gain (loss) on |
||||||||
Futures contracts |
( |
) | ||||||
Short-term U.S. government and agency obligations |
( |
) | ||||||
|
|
|
|
|||||
Net realized gain (loss) |
( |
) | ||||||
|
|
|
|
|||||
Change in net unrealized appreciation (depreciation) on |
||||||||
Futures contracts |
||||||||
Short-term U.S. government and agency obligations |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Change in net unrealized appreciation (depreciation) |
||||||||
|
|
|
|
|||||
Net realized and unrealized gain (loss) |
( |
) | ||||||
|
|
|
|
|||||
Net income (loss) |
$ | $ | ( |
) | ||||
|
|
|
|
Three Months Ended March 31, |
||||||||
2023 |
2022 |
|||||||
Shareholders’ equity, beginning of period |
$ | $ | ||||||
Addition of |
||||||||
Redemption of |
( |
) | ( |
) | ||||
Net addition (redemption) of ( |
( |
) | ||||||
Net investment income (loss) |
( |
) | ||||||
Net realized gain (loss) |
( |
) | ||||||
Change in net unrealized appreciation (depreciation) |
||||||||
Net income (loss) |
( |
) | ||||||
Shareholders’ equity, end of period |
$ | $ | ||||||
Three Months Ended March 31, |
||||||||
2023 |
2022 |
|||||||
Cash flow from operating activities |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
||||||||
Purchases of short-term U.S. government and agency obligations |
( |
) | ( |
) | ||||
Proceeds from sales or maturities of short-term U.S. government and agency obligations |
||||||||
Net amortization and accretion on short-term U.S. government and agency obligations |
( |
) | ( |
) | ||||
Net realized (gain) loss on investments |
— | |||||||
Change in unrealized (appreciation) depreciation on investments |
||||||||
Decrease (Increase) in receivable on open futures contracts |
||||||||
Decrease (Increase) in interest receivable |
||||||||
Increase (Decrease) in payable to Sponsor |
( |
) | ||||||
Increase (Decrease) in brokerage commissions and futures account fees payable |
( |
) | ( |
) | ||||
Increase (Decrease) in payable on open futures contracts |
— | |||||||
Net cash provided by (used in) operating activities |
( |
) | ||||||
Cash flow from financing activities |
||||||||
Proceeds from addition of shares |
||||||||
Payment on shares redeemed |
( |
) | ( |
) | ||||
Net cash provided by (used in) financing activities |
( |
) | ||||||
Net increase (decrease) in cash |
||||||||
Cash, beginning of period |
||||||||
Cash, end of period |
$ | $ | ||||||
March 31, 2023 (unaudited) |
December 31, 2022 |
|||||||
Assets |
||||||||
Short-term U.S. government and agency obligations (Note 3) (cost $ |
$ | $ | ||||||
Cash |
||||||||
Segregated cash balances with brokers for futures contracts |
||||||||
Segregated cash balances with brokers for swap agreements |
||||||||
Unrealized appreciation on swap agreements |
||||||||
Receivable on open futures contracts |
||||||||
Interest receivable |
||||||||
Total assets |
||||||||
Liabilities and shareholders’ equity |
||||||||
Liabilities |
||||||||
Payable for capital shares redeemed |
||||||||
Brokerage commissions and futures account fees payable |
||||||||
Payable to Sponsor |
||||||||
Unrealized depreciation on swap agreements |
||||||||
Total liabilities |
||||||||
Commitments and Contingencies (Note 2) |
||||||||
Shareholders’ equity |
||||||||
Shareholders’ equity |
||||||||
Total liabilities and shareholders’ equity |
$ | $ | ||||||
Shares outstanding (Note 1) |
||||||||
Net asset value per share (Note 1) |
$ | $ | ||||||
Market value per share (Note 1) (Note 2) |
$ | $ | ||||||
Principal Amount |
Value |
|||||||
Short-term U.S. government and agency obligations |
||||||||
( |
||||||||
U.S. Treasury Bills ^^ : |
||||||||
† |
$ | $ | ||||||
† |
||||||||
† |
||||||||
Total short-term U.S. government and agency obligations |
||||||||
(cost $ |
$ | |||||||
Number of Contracts |
Notional Amount at Value |
Unrealized Appreciation (Depreciation)/Value |
||||||||||
WTI Crude Oil – NYMEX, expires June 2023 |
$ | $ | ||||||||||
WTI Crude Oil – NYMEX, expires December 2023 |
||||||||||||
WTI Crude Oil – NYMEX, expires June 2024 |
||||||||||||
$ | ||||||||||||
Rate Paid (Received) * |
Termination Date |
Notional Amount at Value ** |
Unrealized Appreciation (Depreciation)/Value |
|||||||||||||
Swap agreement with Citibank, N.A. based on Bloomberg Commodity Balanced WTI Crude Oil Index |
% | $ | $ | ( |
) | |||||||||||
Swap agreement with Goldman Sachs International based on Bloomberg Commodity Balanced WTI Crude Oil Index |
( |
) | ||||||||||||||
Swap agreement with Morgan Stanley & Co. International PLC based on Bloomberg Commodity Balanced WTI Crude Oil Index |
( |
) | ||||||||||||||
Swap agreement with Societe Generale based on Bloomberg Commodity Balanced WTI Crude Oil Index |
( |
) | ||||||||||||||
Swap agreement with UBS AG based on Bloomberg Commodity Balanced WTI Crude Oil Index |
( |
) | ||||||||||||||
Total Unrealized Depreciation |
$ | ( |
) | |||||||||||||
† | All or partial amount pledged as collateral for swap agreements. |
^ | The positions and counterparties herein are as of March 31, 2023. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time. |
^^ |
* | Reflects the floating financing rate, as of March 31, 2023, on the notional amount of the swap agreement paid to the counterparty or received from the counterparty, excluding any commissions. Total Return Swap Agreements payment is due at termination/maturity. |
** | For swap agreements, a positive amount represents “long” exposure to the benchmark index. A negative amount represents “short” exposure to the benchmark index. |
Three Months Ended March 31, |
||||||||
2023 |
2022 |
|||||||
Investment Income |
||||||||
Interest |
$ | $ | ||||||
|
|
|
|
|||||
Expenses |
||||||||
Management fee |
||||||||
Brokerage commissions |
||||||||
Futures accounts fees |
||||||||
|
|
|
|
|||||
Total expenses |
||||||||
|
|
|
|
|||||
Net investment income (loss) |
( |
) | ||||||
|
|
|
|
|||||
Realized and unrealized gain (loss) on investment activity |
||||||||
Net realized gain (loss) on |
||||||||